Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Healthcare BPO Market

ID: MRFR/HCIT/16497-CR
100 Pages
Vikita Thakur
Last Updated: January 29, 2026

US Healthcare BPO Market Research Report: Size, Share, Trend Analysis By Service (Payer Services, Provider Services, Pharmaceutical Services) By Patient Care (Medical Transcription, Device Monitoring) By Payer Services (Claims Management, Integrated Front-End Services & Back-Office Operations, Member Management, Product Development and Business Acquisition Services, Provider Management Services, Care Management Solutions, Billing and Accounts Management Services, Others) By Claims Management (Claims Adjudication Services, Claims Settlement Services, Information Management Services, Claims Repricing, Claims Investigation Services, Claims Indexing Services, Fraud Detection and Management) By Provider Services (Revenue Cycle Management, Patient Enrollment, Patient Care, Others) By Research & Development,Manufacturing, Non-Clinical Services, Supply Chain Management & Logistics, Sales and Marketing Services, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Healthcare BPO Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Industrial Automation & Equipment, BY Service (USD Billion)
  49.     4.1.1 Payer Services
  50.     4.1.2 Provider Services
  51.     4.1.3 Pharmaceutical Services
  52.   4.2 Industrial Automation & Equipment, BY Payer Services (USD Billion)
  53.     4.2.1 Claims Management
  54.     4.2.2 Integrated Front-End Services & Back-Office Operations
  55.     4.2.3 Member Management
  56.     4.2.4 Product Development and Business Acquisition Services
  57.     4.2.5 Provider Management Services
  58.     4.2.6 Care Management Solutions
  59.     4.2.7 Billing and Accounts Management Services
  60.     4.2.8 Others
  61.   4.3 Industrial Automation & Equipment, BY Claims Management (USD Billion)
  62.     4.3.1 Claims Adjudication Services
  63.     4.3.2 Claims Settlement Services
  64.     4.3.3 Information Management Services
  65.     4.3.4 Claims Repricing
  66.     4.3.5 Claims Investigation Services
  67.     4.3.6 Claims Indexing Services
  68.     4.3.7 Fraud Detection and Management
  69.   4.4 Industrial Automation & Equipment, BY Provider Services (USD Billion)
  70.     4.4.1 Revenue Cycle Management
  71.     4.4.2 Patient Enrollment
  72.     4.4.3 Patient Care
  73.     4.4.4 Others
  74.   4.5 Industrial Automation & Equipment, BY Patient Care (USD Billion)
  75.     4.5.1 Medical Transcription
  76.     4.5.2 Device Monitoring
  77.   4.6 Industrial Automation & Equipment, BY Pharmaceutical Services (USD Billion)
  78.     4.6.1 Research & Development
  79.     4.6.2 Manufacturing
  80.     4.6.3 Non-Clinical Services
  81.     4.6.4 Supply Chain Management & Logistics
  82.     4.6.5 Sales and Marketing Services
  83.     4.6.6 Others
  84. 5 SECTION V: COMPETITIVE ANALYSIS
  85.   5.1 Competitive Landscape
  86.     5.1.1 Overview
  87.     5.1.2 Competitive Analysis
  88.     5.1.3 Market share Analysis
  89.     5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
  90.     5.1.5 Competitive Benchmarking
  91.     5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
  92.     5.1.7 Key developments and growth strategies
  93.       5.1.7.1 New Product Launch/Service Deployment
  94.       5.1.7.2 Merger & Acquisitions
  95.       5.1.7.3 Joint Ventures
  96.     5.1.8 Major Players Financial Matrix
  97.       5.1.8.1 Sales and Operating Income
  98.       5.1.8.2 Major Players R&D Expenditure. 2023
  99.   5.2 Company Profiles
  100.     5.2.1 Cognizant Technology Solutions (US)
  101.       5.2.1.1 Financial Overview
  102.       5.2.1.2 Products Offered
  103.       5.2.1.3 Key Developments
  104.       5.2.1.4 SWOT Analysis
  105.       5.2.1.5 Key Strategies
  106.     5.2.2 TCS (IN)
  107.       5.2.2.1 Financial Overview
  108.       5.2.2.2 Products Offered
  109.       5.2.2.3 Key Developments
  110.       5.2.2.4 SWOT Analysis
  111.       5.2.2.5 Key Strategies
  112.     5.2.3 Genpact (IN)
  113.       5.2.3.1 Financial Overview
  114.       5.2.3.2 Products Offered
  115.       5.2.3.3 Key Developments
  116.       5.2.3.4 SWOT Analysis
  117.       5.2.3.5 Key Strategies
  118.     5.2.4 Wipro (IN)
  119.       5.2.4.1 Financial Overview
  120.       5.2.4.2 Products Offered
  121.       5.2.4.3 Key Developments
  122.       5.2.4.4 SWOT Analysis
  123.       5.2.4.5 Key Strategies
  124.     5.2.5 Accenture (IE)
  125.       5.2.5.1 Financial Overview
  126.       5.2.5.2 Products Offered
  127.       5.2.5.3 Key Developments
  128.       5.2.5.4 SWOT Analysis
  129.       5.2.5.5 Key Strategies
  130.     5.2.6 HCL Technologies (IN)
  131.       5.2.6.1 Financial Overview
  132.       5.2.6.2 Products Offered
  133.       5.2.6.3 Key Developments
  134.       5.2.6.4 SWOT Analysis
  135.       5.2.6.5 Key Strategies
  136.     5.2.7 Teleperformance (FR)
  137.       5.2.7.1 Financial Overview
  138.       5.2.7.2 Products Offered
  139.       5.2.7.3 Key Developments
  140.       5.2.7.4 SWOT Analysis
  141.       5.2.7.5 Key Strategies
  142.     5.2.8 Sunknowledge Services Inc (US)
  143.       5.2.8.1 Financial Overview
  144.       5.2.8.2 Products Offered
  145.       5.2.8.3 Key Developments
  146.       5.2.8.4 SWOT Analysis
  147.       5.2.8.5 Key Strategies
  148.     5.2.9 Vee Technologies (US)
  149.       5.2.9.1 Financial Overview
  150.       5.2.9.2 Products Offered
  151.       5.2.9.3 Key Developments
  152.       5.2.9.4 SWOT Analysis
  153.       5.2.9.5 Key Strategies
  154.   5.3 Appendix
  155.     5.3.1 References
  156.     5.3.2 Related Reports
  157. 6 LIST OF FIGURES
  158.   6.1 MARKET SYNOPSIS
  159.   6.2 US MARKET ANALYSIS BY SERVICE
  160.   6.3 US MARKET ANALYSIS BY PAYER SERVICES
  161.   6.4 US MARKET ANALYSIS BY CLAIMS MANAGEMENT
  162.   6.5 US MARKET ANALYSIS BY PROVIDER SERVICES
  163.   6.6 US MARKET ANALYSIS BY PATIENT CARE
  164.   6.7 US MARKET ANALYSIS BY PHARMACEUTICAL SERVICES
  165.   6.8 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
  166.   6.9 RESEARCH PROCESS OF MRFR
  167.   6.10 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
  168.   6.11 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
  169.   6.12 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
  170.   6.13 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
  171.   6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY SERVICE, 2024 (% SHARE)
  172.   6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY SERVICE, 2024 TO 2035 (USD Billion)
  173.   6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY PAYER SERVICES, 2024 (% SHARE)
  174.   6.17 INDUSTRIAL AUTOMATION & EQUIPMENT, BY PAYER SERVICES, 2024 TO 2035 (USD Billion)
  175.   6.18 INDUSTRIAL AUTOMATION & EQUIPMENT, BY CLAIMS MANAGEMENT, 2024 (% SHARE)
  176.   6.19 INDUSTRIAL AUTOMATION & EQUIPMENT, BY CLAIMS MANAGEMENT, 2024 TO 2035 (USD Billion)
  177.   6.20 INDUSTRIAL AUTOMATION & EQUIPMENT, BY PROVIDER SERVICES, 2024 (% SHARE)
  178.   6.21 INDUSTRIAL AUTOMATION & EQUIPMENT, BY PROVIDER SERVICES, 2024 TO 2035 (USD Billion)
  179.   6.22 INDUSTRIAL AUTOMATION & EQUIPMENT, BY PATIENT CARE, 2024 (% SHARE)
  180.   6.23 INDUSTRIAL AUTOMATION & EQUIPMENT, BY PATIENT CARE, 2024 TO 2035 (USD Billion)
  181.   6.24 INDUSTRIAL AUTOMATION & EQUIPMENT, BY PHARMACEUTICAL SERVICES, 2024 (% SHARE)
  182.   6.25 INDUSTRIAL AUTOMATION & EQUIPMENT, BY PHARMACEUTICAL SERVICES, 2024 TO 2035 (USD Billion)
  183.   6.26 BENCHMARKING OF MAJOR COMPETITORS
  184. 7 LIST OF TABLES
  185.   7.1 LIST OF ASSUMPTIONS
  186.     7.1.1
  187.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  188.     7.2.1 BY SERVICE, 2025-2035 (USD Billion)
  189.     7.2.2 BY PAYER SERVICES, 2025-2035 (USD Billion)
  190.     7.2.3 BY CLAIMS MANAGEMENT, 2025-2035 (USD Billion)
  191.     7.2.4 BY PROVIDER SERVICES, 2025-2035 (USD Billion)
  192.     7.2.5 BY PATIENT CARE, 2025-2035 (USD Billion)
  193.     7.2.6 BY PHARMACEUTICAL SERVICES, 2025-2035 (USD Billion)
  194.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  195.     7.3.1
  196.   7.4 ACQUISITION/PARTNERSHIP
  197.     7.4.1

US Industrial Automation & Equipment Market Segmentation

Industrial Automation & Equipment By Service (USD Billion, 2025-2035)

  • Payer Services
  • Provider Services
  • Pharmaceutical Services

Industrial Automation & Equipment By Payer Services (USD Billion, 2025-2035)

  • Claims Management
  • Integrated Front-End Services & Back-Office Operations
  • Member Management
  • Product Development and Business Acquisition Services
  • Provider Management Services
  • Care Management Solutions
  • Billing and Accounts Management Services
  • Others

Industrial Automation & Equipment By Claims Management (USD Billion, 2025-2035)

  • Claims Adjudication Services
  • Claims Settlement Services
  • Information Management Services
  • Claims Repricing
  • Claims Investigation Services
  • Claims Indexing Services
  • Fraud Detection and Management

Industrial Automation & Equipment By Provider Services (USD Billion, 2025-2035)

  • Revenue Cycle Management
  • Patient Enrollment
  • Patient Care
  • Others

Industrial Automation & Equipment By Patient Care (USD Billion, 2025-2035)

  • Medical Transcription
  • Device Monitoring

Industrial Automation & Equipment By Pharmaceutical Services (USD Billion, 2025-2035)

  • Research & Development
  • Manufacturing
  • Non-Clinical Services
  • Supply Chain Management & Logistics
  • Sales and Marketing Services
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓